We previously demonstrated that IGFBP-3 inhibits the growth of NSCLC cells in vitro and in vivo via the PKB/Akt and MAPK signaling pathways, which are activated by IGF-mediated signaling pathways and play important roles in cell survival [10]. This evidence concerns the gene IGF1 and non-small cell lung carcinoma.